Last reviewed · How we verify

NCT06163768

Effects of Insulin Resistance in Non-diabetic Acute Coronary Syndrome Patients

Recruiting now NA Last updated 11 December 2023
What this trial tests

NA trial testing Insulin resistance in Insulin Resistance in 1 participant. Currently enrolling.

Timeline
31 December 2023
Primary endpoint
31 October 2026
30 December 2026

Quick facts

Lead sponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment1
Start date31 December 2023
Primary completion31 October 2026
Estimated completion30 December 2026
Sites1 location across Vietnam

Drugs / interventions tested

Conditions studied

Sponsor

University of Medicine and Pharmacy at Ho Chi Minh City

Who can join

Adults 18 to 60, any sex, with Insulin Resistance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Effects of insulin resistance in non-diabetic acute coronary syndrome patients by the homeostasis model assessment index (HOMA2-IR)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Insulin Resistance

Currently open trials in the same condition.

Other University of Medicine and Pharmacy at Ho Chi Minh City trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06163768.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing